Showing results (731-740 of 1,633) with videos related to
Sort By:
Pageof 164
Expert Review of Clinical Pharmacology|January 26, 2022
Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performanceHasumati Rahalkar, Alan Sheppard, Sam SalekExpert Review of Clinical Pharmacology|June 30, 2018
Triptorelin depot for the treatment of children 2 years and older with central precocious pubertySilvano Bertelloni, Cristina Mucaria, Giampiero I Baroncelli, et al.Expert Review of Clinical Pharmacology|June 30, 2018
Chronic abdominal pain in irritable bowel syndrome - current and future therapiesAnna Zielińska, Maciej Sałaga, Marcin Włodarczyk, et al.Expert Review of Clinical Pharmacology|May 19, 2018
Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infectionJose L Casado, Marta Monsalvo, Aurora M Rojo, et al.Expert Review of Clinical Pharmacology|June 12, 2014
Treating chronic pain: the need for non-opioid optionsEric L GarlandExpert Review of Clinical Pharmacology|November 14, 2022
A model based on machine learning for the prediction of cyclosporin A trough concentration in Chinese allo-HSCT patientsLin Song, Chen-Rong Huang, Shi-Zheng Pan, et al.Expert Review of Clinical Pharmacology|March 27, 2023
Parametric population pharmacokinetics of isoniazid: a systematic reviewJinmeng Li, Xinjun Cai, Yueting Chen, et al.Expert Review of Clinical Pharmacology|August 26, 2022
Samidorphan for the treatment of weight gain associated with olanzapine in patients with schizophrenia and bipolar disorderJunfa Gao, Junsheng Li, Xiuhua Lu, et al.Expert Review of Clinical Pharmacology|August 1, 2022
Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuriaNasir Shah, Vlado Perkovic, Sradha KotwalExpert Review of Clinical Pharmacology|March 8, 2023
Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trialZhongnan Xu, Zhengzhi Liu, Yanli Wang, et al.Pageof 164